BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
JB’s Q4FY23 result was largely in-line with our estimates.
Sales stood at Rs7.6bn slightly above our estimate of Rs7.2bn, (grew by 22.1% YoY) driven by market beating performance by domestic business and higher CMO sales. Gross margins at 63.9% (abv est) contracted 198bps YoY and expanded 166bps QoQ. EBITDA at Rs1.64bn grew by 16.9% YoY/declined by 6.4% QoQ, EBITDA margin at 21.5% slightly below our est of 22.2% (-94bps/- 58bps YoY/QoQ) due to higher than expected other operating expenses. Excluding ESOP cost, EBITDA margin was at 23.7%.
We upgrade our EPS estimates by 3%/6.5% in FY24E/FY25E assuming higher than expected sales and EBITDA margin. Maintain Buy with TP of Rs2,536.
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
.jpeg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
PVR-INOX Q2 Results Review - Sequential Recovery; Q3 Likely To Be Robust: Motilal Oswal
Oct 16, 2024
JLR Retail Sales Rises 36% To 3,214 units In First Half Of FY25
Oct 15, 2024
Reliance Industries Q2 Review - Weaker Oil-To-Chemical, Retail Dragged Ebitda; Upgrade To Buy: Systematix
Oct 15, 2024
Piramal Pharma - Geared To Drive Robust Operating Leverage Across Segments: Motilal Oswal
Sep 25, 2024
POPULAR